| P2093 | author name string | David M Ledgerwood | |
| | Russell Yskes | |
| P2860 | cites work | Pharmacological interventions for smoking cessation: an overview and network meta-analysis | Q24202961 |
| | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| | Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis | Q24598338 |
| | A test of motivational plus nicotine replacement interventions for HIV positive smokers | Q30436089 |
| | Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials | Q33395936 |
| | Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007. | Q33529099 |
| | Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study | Q33787430 |
| | Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial | Q33997418 |
| | Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial | Q34064160 |
| | Evaluation of a Smoking Cessation Program for HIV Infected Individuals in an Urban HIV Clinic: Challenges and Lessons Learned | Q34347186 |
| | Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy | Q34403321 |
| | The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans | Q34724611 |
| | Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). | Q34762935 |
| | Healthcare provider intervention on smoking and quit attempts among HIV-positive versus HIV-negative MSM smokers in Chengdu, China | Q35001304 |
| | Are smokers with HIV using information and communication technology? Implications for behavioral interventions | Q35473723 |
| | Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study | Q35623357 |
| | Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes | Q35624478 |
| | An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial | Q35861451 |
| | Plastic apron wear during direct patient care | Q36279025 |
| | Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans | Q36417071 |
| | Safety of varenicline among smokers enrolled in the lung HIV study | Q36471990 |
| | Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. | Q36554948 |
| | Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS. | Q36592177 |
| | A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers | Q36598793 |
| | Improved adherence with contingency management | Q36722399 |
| | Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing | Q36763788 |
| | Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals | Q36916197 |
| | Effects of smoking on non-AIDS-related morbidity in HIV-infected patients | Q36946246 |
| | A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings | Q37024805 |
| | Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. | Q37037012 |
| | A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. | Q37049790 |
| | Motivation and patch treatment for HIV+ smokers: a randomized controlled trial | Q37389719 |
| | Contingency management for smoking cessation: where do we go from here? | Q37561309 |
| | Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers | Q37600952 |
| | Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians | Q38434908 |
| | Smoking motivations and quitting motivations among HIV-infected smokers | Q39297498 |
| | The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. | Q39816403 |
| | Dose-related reduction in bupropion plasma concentrations by ritonavir | Q43059456 |
| | Varenicline and antiretroviral therapy in patients with HIV. | Q43236461 |
| | Smoking cessation in HIV patients: rate of success and associated factors. | Q43297631 |
| | Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects | Q44188352 |
| | 21st-century hazards of smoking and benefits of cessation in the United States | Q44235905 |
| | A prospective trial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients | Q44346818 |
| | Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study | Q44486385 |
| | Combination antiretroviral therapy and the risk of myocardial infarction | Q44662157 |
| | Smoking behavior in a low-income multiethnic HIV/AIDS population | Q44775914 |
| | Smoking cessation efforts in one New York city HIV clinic | Q44809509 |
| | Increasing access to smoking cessation treatment in a low-income, HIV-positive population: the feasibility of using cellular telephones | Q44941668 |
| | Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection | Q45103906 |
| | Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy | Q45251005 |
| | Addressing smoking during medical visits: patients with human immunodeficiency virus | Q45354289 |
| | Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey | Q46150902 |
| | Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects | Q46260779 |
| | Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation | Q46382491 |
| | Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers | Q46446691 |
| | HIV symptom distress and smoking outcome expectancies among HIV+ smokers: a pilot test | Q46638476 |
| | Tobacco use and readiness to quit smoking in low-income HIV-infected persons | Q46639165 |
| | Cigarette smoking and the desire to quit among individuals living with HIV. | Q46679966 |
| | Smoking cessation for clients who are HIV-positive | Q46848560 |
| | Contingency management in group treatment: a demonstration project in an HIV drop-in center | Q48367090 |
| | Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individuals living with HIV/AIDS. | Q50901193 |
| | A smoking cessation programme in HIV-infected individuals: a pilot study. | Q51921981 |
| | Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort. | Q53683491 |
| | Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study | Q57313883 |
| | Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial | Q58000817 |
| | The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers | Q73201136 |
| | Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects | Q79448424 |
| | Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers | Q83201640 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV/AIDS | Q12199 |
| | literature review | Q2412849 |
| P304 | page(s) | 2177-2184 | |
| P577 | publication date | 2016-05-31 | |
| P1433 | published in | Nicotine and Tobacco Research | Q15762854 |
| P1476 | title | Smoking Cessation for People Living With HIV/AIDS: A Literature Review and Synthesis | |
| P478 | volume | 18 | |